Nadim El‐Awar

1.5k total citations
34 papers, 1.3k citations indexed

About

Nadim El‐Awar is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Transplantation. According to data from OpenAlex, Nadim El‐Awar has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 15 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Transplantation. Recurrent topics in Nadim El‐Awar's work include T-cell and B-cell Immunology (17 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Renal Transplantation Outcomes and Treatments (14 papers). Nadim El‐Awar is often cited by papers focused on T-cell and B-cell Immunology (17 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Renal Transplantation Outcomes and Treatments (14 papers). Nadim El‐Awar collaborates with scholars based in United States, Mexico and Italy. Nadim El‐Awar's co-authors include Paul I. Terasaki, Luis E. Morales‐Buenrostro, Jar-How Lee, Anh Nguyen, Junchao Cai, Josefina Alberú, P. I. Terasaki, Hugo Kaneku, Mepur H. Ravindranath and Nori Sasaki and has published in prestigious journals such as The Lancet, The Journal of Immunology and Transplantation.

In The Last Decade

Nadim El‐Awar

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadim El‐Awar United States 18 859 588 512 171 159 34 1.3k
Hugo Kaneku United States 21 1.2k 1.4× 304 0.5× 1.1k 2.1× 43 0.3× 120 0.8× 41 1.5k
Kazuo Mizutani United States 11 531 0.6× 233 0.4× 368 0.7× 33 0.2× 80 0.5× 30 744
Chantal Eijsink Netherlands 12 255 0.3× 314 0.5× 155 0.3× 54 0.3× 105 0.7× 16 596
J Everly United States 7 496 0.6× 211 0.4× 316 0.6× 23 0.1× 100 0.6× 10 760
Afzal Nikaein United States 13 263 0.3× 290 0.5× 245 0.5× 70 0.4× 92 0.6× 35 693
Helena Genberg Sweden 14 824 1.0× 234 0.4× 505 1.0× 24 0.1× 151 0.9× 17 1.1k
Natacha Patey‐Mariaud de Serre France 14 74 0.1× 296 0.5× 261 0.5× 77 0.5× 163 1.0× 21 828
E. Felber Germany 9 299 0.3× 272 0.5× 168 0.3× 25 0.1× 37 0.2× 11 527
Jochen Wilpert Germany 15 427 0.5× 94 0.2× 296 0.6× 11 0.1× 76 0.5× 17 776
Thuong Hien Tran Germany 16 425 0.5× 285 0.5× 248 0.5× 6 0.0× 141 0.9× 45 743

Countries citing papers authored by Nadim El‐Awar

Since Specialization
Citations

This map shows the geographic impact of Nadim El‐Awar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadim El‐Awar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadim El‐Awar more than expected).

Fields of papers citing papers by Nadim El‐Awar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadim El‐Awar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadim El‐Awar. The network helps show where Nadim El‐Awar may publish in the future.

Co-authorship network of co-authors of Nadim El‐Awar

This figure shows the co-authorship network connecting the top 25 collaborators of Nadim El‐Awar. A scholar is included among the top collaborators of Nadim El‐Awar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadim El‐Awar. Nadim El‐Awar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lachmann, Nils, Constanze Schönemann, Nadim El‐Awar, et al.. (2016). Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy. Nephrology Dialysis Transplantation. 31(8). 1351–1359. 21 indexed citations
4.
Nikaein, Afzal, Nadim El‐Awar, Judson Hunt, et al.. (2011). Clinically irrelevant circulating human leukocyte antigen antibodies in the presence of ventricular assist devices. The Journal of Heart and Lung Transplantation. 31(5). 443–447. 17 indexed citations
5.
El‐Awar, Nadim, et al.. (2010). New HLA class I epitopes defined by murine monoclonal antibodies. Human Immunology. 71(5). 456–461. 13 indexed citations
6.
Ravindranath, Mepur H., Hugo Kaneku, & Nadim El‐Awar. (2010). HLA-E monoclonal antibody MEM-E/02 binds to discontinuous but shared peptide sequences on HLA B & C heavy chains not treated by acid. Molecular Immunology. 47(9). 1663–1664. 4 indexed citations
7.
Ravindranath, Mepur H., Tho D. Pham, Nadim El‐Awar, Hugo Kaneku, & Paul I. Terasaki. (2010). Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies. Molecular Immunology. 48(4). 423–430. 31 indexed citations
8.
El‐Awar, Nadim, Paul I. Terasaki, Anh Nguyen, et al.. (2009). Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. Human Immunology. 70(10). 844–853. 115 indexed citations
9.
Ravindranath, Mepur H., Michiko Taniguchi, Miyuki Ozawa, et al.. (2009). HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: Relevance to human natural HLA antibodies. Molecular Immunology. 47(5). 1121–1131. 35 indexed citations
10.
El‐Awar, Nadim, et al.. (2008). Human Leukocyte Antigen Class II DQ Alpha and Beta Epitopes Identified From Sera of Kidney Allograft Recipients. Transplantation. 86(3). 452–459. 43 indexed citations
11.
Morales‐Buenrostro, Luis E., et al.. (2008). “Natural” Human Leukocyte Antigen Antibodies Found in Nonalloimmunized Healthy Males. Transplantation. 86(8). 1111–1115. 245 indexed citations
12.
El‐Awar, Nadim, Tatsuya Akaza, Paul I. Terasaki, & Anh Nguyen. (2007). Human Leukocyte Antigen Class I Epitopes: Update to 103 Total Epitopes, Including the C Locus. Transplantation. 84(4). 532–540. 63 indexed citations
13.
Cai, Junchao, et al.. (2007). HLA class II DP epitopes.. PubMed. 195–202. 6 indexed citations
14.
Terasaki, Paul I., et al.. (2007). Analysis of HLA Class I Specific Antibodies in Patients with Failed Allografts. Transplantation. 83(1). 54–61. 36 indexed citations
15.
Cai, Junchao, et al.. (2006). HLA class II DQ epitopes.. PubMed. 115–22. 11 indexed citations
16.
Cai, Junchao, Paul I. Terasaki, Qiuxia Mao, et al.. (2006). Development of Nondonor-Specific HLA-DR Antibodies in Allograft Recipients Is Associated with Shared Epitopes with Mismatched Donor DR Antigens. American Journal of Transplantation. 6(12). 2947–2954. 66 indexed citations
17.
Akaza, Tatsuya, et al.. (2006). HLA class I epitopes: C-locus.. PubMed. 95–102. 6 indexed citations
18.
Qiu, Jianxin, et al.. (2005). Detection of Antibodies to HLA-DP in Renal Transplant Recipients Using Single Antigen Beads. Transplantation. 80(10). 1511–1513. 53 indexed citations
19.
El‐Awar, Nadim, et al.. (2005). HLA Antibody Identification With Single Antigen Beads Compared To Conventional Methods. Human Immunology. 66(9). 989–997. 100 indexed citations
20.
El‐Awar, Nadim, et al.. (2002). MOST PATIENTS WHO REJECT A KIDNEY TRANSPLANT HAVE ANTI‐HLA‐ANTIBODIES. Tissue Antigens. 60(6). 553–553. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026